Wang, Yachun
Tan, Jiao
Lei, Lei
Yuan, Yingying
Li, Wenbo
Zhao, Yue
Wang, Yali
Niu, Xiaodong
Li, Zheng
Wei, Lukuan
Han, Yungang
Cheng, Meijing
Guo, Xu
Han, Xue
Wang, Wei
Article History
Received: 15 October 2022
Accepted: 12 December 2022
First Online: 20 December 2022
Declarations
:
: This research was approved by the Ethical Committee of the leading hospital, Henan Province Chest Hospital (No. 2018-007-02). As only routine samples were used in this study, the review committee waived the requirement for individual informed consent. Following the policy issued by the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council on Deepening the Reform of the Evaluation and Approval Systems and Encouraging Innovation on Drugs and Medical Devices, after the ethics committee of the Clinical Trials Leaders Institute for this multi-center study obtained ethical approval, all other authors endorsed and accepted the conclusions of the lead unit's ethics committee.
: Not applicable.
: None to declare.